Discovery, Characterization, & Advancement, of Novel Chemotypes of Potent & Selective Brain Penetrant & Peripherally Restricted NLRP3 Inhibitors

Time: 9:30 am
day: Day Two

Details:

  • Exploring the drug discovery process: target identification and validation,
    efficacy, pathway understanding and biomarkers
  • Discussing biomarker and patient status
  • Reviewing latest data and future directions

Speakers: